Introduction and objectives:
With the rising number of contact lens users, there has been observed an increasing number of patients admitted to ophthalmology wards with severe keratitis, including those of fungal etiology. One of the most devastating specimens is Fusarium spp. If not diagnosed and treated from the onset of the symptoms, it can lead to severe visual loss, or even blindness.

Case report:
This a retrospective case report of a 36-year-old pregnant female diagnosed with Fusarium keratitis, not responding to topical treatment. The problem is discussed and includes the most relevant literature review.

Primary therapeutic keratoplasty is prone to failure due to an ongoing inflammation process in the eye, as happened in the described patient. Spread of the infection to the vitreous body necessitated the procedure of penetrating keratoplasty with lens removal, pars plana vitrectomy and silicone oil. After treatment, the inflammation resolved, and best corrected visual acuity at the 6 months follow-up was 0.5 (Snellen charts).

There is currently no treatment for Fusarium keratitis that would offer similar results to those observed in bacterial infection treated early with antibiotics. As systemic therapy with antifungal agents is not an option in pregnant women, they are even more of a challenge. Diagnosis is quite often delayed, leading to deeper infiltration of the cornea, sometimes with vitreous involvement. For such cases, a combined approach is proposed with vitrectomy, lens removal and penetrating keratoplasty. Early surgical intervention may rescue some of the eyes non-responsive to topical and systemic treatment.

Garg P, Roy A, Roy S. Update on fungal keratitis. Curr Opin Ophthalmol. 2016; 27(4): 333–339.
Gower EW, Keay LJ, Oechsler RA, Iovieno A, Alfonso EC, Jones DB, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010; 117(12): 2263–7.
Bullock JD, Elder BL, Khamis HJ, Warwar RE. Effects of Time, Temperature, and Storage Container on the Growth of Fusarium Species: Implications for the Worldwide Fusarium Keratitis Epidemic of 2004–2006. Arch Ophthalmol. 2011; 129(2): 133–6.
Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The Epidemiological Features and Laboratory Results of Fungal Keratitis: A 10-Year Review at a Referral Eye Care Center in South India. Cornea. 2002; 21(6): 555–559.
Epstein AB. In the aftermath of the Fusarium keratitis outbreak: What have we learned? Clin Ophthalmol Auckl NZ. 2007; 1(4): 355–66.
Al-Hatmi AMS, Meis JF, de Hoog GS. Fusarium: Molecular Diversity and Intrinsic Drug Resistance. PLoS Pathog. 2016; 12(4).
Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced Fusarium Keratitis Progressing to Endophthalmitis. Cornea. 2003; 22(4): 300–303.
Fusarium Keratitis in Germany. J Clin Microbiol. 2017 Oct; 55(10): 2983–2995. doi: 10.1128/JCM.00649–17
Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M. Microbial Keratitis in South India: Influence of Risk Factors, Climate, and Geographical Variation. Ophthalmic Epidemiol. 2007; 14(2): 61–9.
Leck AK, Thomas PA, Hagan M, Kaliamurthy J, Ackuaku E, John M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002; 86(11): 1211–5.
Cao J, Yang Y, Yang W, Wu R, Xiao X, Yuan J, et al. Prevalence of infectious keratitis in Central China. BMC Ophthalmol. 2014; 14(1): 43.
Alipour F, Khaheshi S, Soleimanzadeh M, Heidarzadeh S, Heydarzadeh S. Contact Lens-related Complications: A Review. J Ophthalmic Vis Res. 2017; 12(2): 193–204.
Tuli SS. Fungal keratitis. Clin Ophthalmol Auckl NZ. 2011; 5: 275–9.
Ansari Z, Miller D, Galor A. Current Thoughts in Fungal Keratitis: Diagnosis and Treatment. Curr Fungal Infect Rep. 2013; 7(3): 209–18.
Maharana PK, Sharma N, Nagpal R, Jhanji V, Das S, Vajpayee RB. Recent advances in diagnosis and management of Mycotic Keratitis. Indian J Ophthalmol. 2016; 64(5): 346–57.
Wu J, Zhang W-S, Zhao J, Zhou H-Y. Review of clinical and basic approaches of fungal keratitis. Int J Ophthalmol. 2016; 9(11): 1676–83.
Chidambaram JD, Prajna NV, Palepu S, Lanjewar S, Shah M, Elakkiya S, et al. Cellular morphological changes detected by laser scanning in vivo confocal microscopy associated with clinical outcome in fungal keratitis. Sci Rep. 06 2019; 9(1): 8334.
Chidambaram JD, Prajna NV, Larke N, Macleod D, Srikanthi P, Lanjewar S, et al. In vivo confocal microscopy appearance of Fusarium and Aspergillus species in fungal keratitis. Br J Ophthalmol. 2017; 101(8): 1119–23.
Tabatabaei SA, Soleimani M, Tabatabaei SM, Beheshtnejad AH, Valipour N, Mahmoudi S. The use of in vivo confocal microscopy to track treatment success in fungal keratitis and to differentiate between Fusarium and Aspergillus keratitis. Int Ophthalmol. 2020; 40(2): 483–91.
Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, et al. Comparison of Natamycin and Voriconazole for the Treatment of Fungal Keratitis. Arch Ophthalmol. 2010; 128(6): 672–8.
Rajaraman R, Bhat P, Vaidee V, Maskibail S, Raghavan A, Sivasubramaniam S, et al. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial. Asia-Pac J Ophthalmol. 2015; 4(3): 146–150.
Klont RR, Eggink CA, Rijs AJMM, Wesseling P, Verweij PE. Successful Treatment ofFusarium Keratitis with Cornea Transplantation and Topical and Systemic Voriconazole. Clin Infect Dis. 2005; 40(12): e110–2.
Heyn K, Tredup A, Salvenmoser S, Müller F-MC. Effect of Voriconazole Combined with Micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother. 2005; 49(12): 5157–9.
Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, et al. The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole. JAMA Ophthalmol. 2013; 131(4): 422–9.
Pradhan L, Sharma S, Nalamada S, Sahu SK, Das S, Garg P. Natamycin in the treatment of keratomycosis: Correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian J Ophthalmol. 2011; 59(6): 512–4.
Sharma N, Chacko J, Velpandian T, Titiyal JS, Sinha R, Satpathy G, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology. 2013; 120(4): 677–81.
Kalaiselvi G, Narayana S, Krishnan T, Sengupta S. Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series. Br J Ophthalmol. 2015; 99(2): 195–8.
Niki M, Eguchi H, Hayashi Y, Miyamoto T, Hotta F, Mitamura Y. Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis. Clin Ophthalmol Auckl NZ. 2014; 8: 1075–9.
Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole. Ophthalmology. 2019; 126(8): 1084–9.
Papaioannou L, Miligkos M, Papathanassiou M. Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis. Cornea. 2016; 35(1): 62–71.
Makdoumi K, Mortensen J, Crafoord S. Infectious Keratitis Treated With Corneal Crosslinking. Cornea. 2010; 29(12): 1353–1358.
Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G. Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol. 2013; 97(5): 669–71.
Galperin G, Berra M, Tau J, Boscaro G, Zarate J, Berra A. Treatment of Fungal Keratitis From Fusarium Infection by Corneal Cross-Linking. Cornea. 2012; 31(2): 176–180.
Wei A, Wang K, Wang Y, Gong L, Xu J, Shao T. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2019; 257(7): 1443–52.
Uddaraju M, Mascarenhas J, Das MR, Radhakrishnan N, Keenan JD, Prajna L, et al. Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial. Am J Ophthalmol. 2015; 160(1): 131–134. e5.
Cross-Linking–Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis. Ophthalmology. 2020; 127(2): 159–66.
Arora T, Arora S, Sharma V. Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis-How to Define Early? Cornea. 2016; 35(6): e14.
Gao H, Song P, Echegaray JJ, Jia Y, Li S, Du M, et al. Big Bubble Deep Anterior Lamellar Keratoplasty for Management of Deep Fungal Keratitis. J Ophthalmol. Hindawi; 2014. s. e209759.
Sabatino F, Sarnicola E, Sarnicola C, Tosi GM, Perri P, Sarnicola V. Early deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment. Eye. 2017; 31(12): 1639–46.
Sarnicola E, Sarnicola C, Sabatino F, Tosi GM, Perri P, Sarnicola V. Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis Poorly Responsive to Medical Treatment: Cornea. 2016; 35(1): 1–5.
Uchio E, Saeki Y, Tsukahara-Kawamura T, Kadonosono K, Ozaki H. Clinical outcome after air-assisted manual deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment. Clin Ophthalmol Auckl NZ. 2019; 13: 1913–9.
Ti S-E, Scott JA, Janardhanan P, Tan DTH. Therapeutic Keratoplasty for Advanced Suppurative Keratitis. Am J Ophthalmol. 2007; 143(5): 755–762. e2.
Chen W-L, Wu C-Y, Hu F-R, Wang I-J. Therapeutic penetrating keratoplasty for microbial keratitis in Taiwan from 1987 to 2001. Am J Ophthalmol. 2004; 137(4): 736–43.
Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk Factors for Treatment Outcome in Fungal Keratitis. Ophthalmology. 2006; 113(4): 526–30.
Xie L, Zhai H, Shi W. Penetrating Keratoplasty for Corneal Perforations in Fungal Keratitis. Cornea. 2007; 26(2): 158–162.
Edelstein SL, Akduman L, Durham BH, Fothergill AW, Hsu HY. Resistant Fusarium Keratitis Progressing to Endophthalmitis. Eye Contact Lens. 2012; 38(5): 331–335.
Rosenberg KD, Flynn HW, Alfonso EC, Miller D. Fusarium Endophthal mitis Following Keratitis Associated With Contact Lenses. Ophthalmic Surg Lasers Imaging Retina. 2006; 37(4): 310–3.
Proença-Pina J, Ssi Yan Kai I, Bourcier T, Fabre M, Offret H, Labetoulle M. Fusarium keratitis and endophthalmitis associated with lens contact wear. Int Ophthalmol. 2010; 30(1): 103–7.